Free

Event Information

Share this event

Date and Time

Location

Location

Altruist Brewing Company

559 Main Street

Sturbridge, MA 01518

View Map

Event description

Description

Are you interested in:

Meeting industry professionals, academics, and graduate students from CT and MA?

Learning more about ACS in your local area?

~NSYCC (Northeastern Section Younger Chemists Committee)

~CMACS (Central Massachusetts American Chemical Society)

~CVS-ACS (Connecticut Valley Section-American Chemical Society)

Learning more about chemical and life science company start-ups and chemistry commercialization in
CT and MA from our fantastic list of speakers?

Enjoying a beer and some food with a bunch of fellow chemistry nerds?

Then come on out to the Joint ACS Brewery Takeover!

We will be coordinating carpooling from the UConn, UMass Amherst and Boston areas to/from this event. When you register for the event, there is a space for you to indicate that you would be interested in carpooling (either looking for a ride or willing to drive others). You should register as early as possible to help us coordinate the carpools.

For inquiries about the event, contact Jessica Martin, CVS-ACS jessica.a.martin@uconn.edu

Joint mixer flier - Massachusetts and Connecticut Local Sections of the American Chemical Society


Speaker Bios:

Jordan Greco (LambdaVision):

Dr. Greco obtained his PhD in Physical Chemistry at the University of Connecticut in 2015. Under the direction of Dr. Robert Birge, Jordan's graduate thesis work primarily involved the investigation of the structure and function of photoactive proteins, using both spectroscopic and quantum mechanical approaches. Much of his work has contributed towards the application of the protein bacteriorhodopsin into photonic and biomimetic devices, such as protein-based optical memories and processors, photovoltaic cells, and the retinal implant developed by LambdaVision. Concurrent with his work on bacteriorhodopsin, Jordan has contributed to numerous computational analyses for the excited state behavior of heterocyclic conjugated compounds (e.g., porphyrin, chlorins, and corroles), carotenoids (e.g., peridinin), and other polyene-based chromophores rooted in biological systems. Dr. Greco has presented this work to international audiences and he continues to remain active in the field via several multidisciplinary collaborations. Since joining the research group of Dr. Birge in 2009, Jordan has been actively involved in the research and development that has led to the creation of the protein-based retinal implant and the commercialization of this technology through LambdaVision. Jordan's graduate thesis work influenced the design and development of the retinal implant construct and the manufacturing techniques that are used to produce the prosthetic. As CSO, Jordan is responsible for manufacturing the retinal implants and establishing standard operating procedures and quality control measures. Moreover, his research efforts helped to direct critical proof-of-concept experiments that investigated the efficacy of the retinal implant architecture.

Nicole Wagner (LambdaVision):

Dr. Wagner obtained her PhD in Molecular and Cell Biology from the University of Connecticut under the advising of Dr. Robert Birge. Nicole entered the graduate program in 2007 and spent the majority of her graduate career working on optimizing retinal-containing proteins for application in devices. During the course of her PhD research, she played a critical role in the proof-of-concept experiments, which helped to found LambdaVision in May 2009. Through the use of site-directed mutagenesis, site-specific saturation mutagenesis, and directed evolution, Nicole was able to genetically engineer the protein, bacteriorhodopsin, for a variety of device applications, including protein-based holographic and 3-dimensional memories, a chemical detection sensor, and, most recently, a protein-based retinal implant. Nicole is an accomplished scientist and entrepreneur with numerous peer-reviewed publications, and has presented her research at both National and International meetings. In 2012, Dr. Wagner received the Connecticut Technology Council’s Women of Innovation “Collegian Innovation and Leadership Award” for her work with LambdaVision, and most recently was listed as one of CT Magazine’s 40 under 40 for the class of 2015. Nicole currently serves as LambdaVision’s President and CEO. Since taking on the role of CEO, Dr. Wagner has been successful in securing over $1.5M in local, state, and government funding to accelerate the research, development, and commercialization of LambdaVision’s retinal implant.

Chittoor Narahari ("Hari") (Moderna Inc):

Chittoor Narahari ("Hari") is currently a Principal Engineer with Moderna Inc., a messenger RNA (mRNA) based therapeutics company in Cambridge. He has extensive experience in early and late phase development of biotherapeutics as well as supporting commercially marketed products. Prior to Moderna, he worked with several Pharmaceuticals and Biotech companies such as GSK, BMS, Amgen, etc. His professional interests include process development, scale-up, Technology transfer and commercialization. He has authored PDA (Parenteral Drugs Association) sponsored best practices guide on Technology Transfer and has Chaired international workshops on commercialization as well as being a Reviewer for ISPE (International Society of Pharmaceuticals Engineers) Baseline guides. He has a Ph. D. in Chemical and Biochemical Engineering from University of Maryland and Undergraduate degree in Chemical Engineering from India.

Elizabeth Wagoner (ProVerde):

Elizabeth (Lizzy) Wagoner graduated Magna Cum Laude from Butler University with a B.S. in Chemistry and Spanish, followed by a Ph.D. in Analytical Chemistry from Indiana University. Upon graduation, she accepted a position at ExxonMobil in Paulsboro, NJ as Analytical Sciences Laboratory Supervisor and Senior Researcher. While working in New Jersey, she lived in Philadelphia, PA and became the chair of the American Chemical Society (ACS) – Philadelphia Section. After several years with ExxonMobil, Lizzy transitioned to a new role as a Senior Researcher and Technical Service Manager at Evonik in Horsham, PA. Due to her avid involvement in the ACS, she participated in many activities with the YCC and other subcommittees. During the Fall 2016 National ACS meeting in Philadelphia, Lizzy attended one of the first events for the ACS Cannabis Chemistry (CANN) subdivision. At this event, she had an opportunity to speak with many of the country’s foremost scientists in the industry. After relocating to Boston, MA she took advantage of her ACS network and became Laboratory Director of ProVerde Laboratories, Inc. ProVerde is a full service, state-of-the-art analytical laboratory providing testing, research and consulting services for the cannabis industry.

In her spare time, Lizzy goes hiking in Massachusetts and New Hampshire with her two rescue dogs and plays Ultimate Frisbee with the Boston Ultimate Disc Alliance.

Ryan Landis (Phytos):

Phytos is an Agrochemical startup out of the University of Massachusetts Amherst. We develop ground-breaking nanotechnology to eliminate infectious disease in agricultural settings. Our first product, Phyto-X, is a platform technology that stabilizes plant oil extracts and other bioactive molecules into a water-sprayable delivery system. Our mission is to create biopesticides that are equally potent as conventional methods while ensuring environmental sustainability. Phytos was founded by Dr. Ryan F. Landis, inventor of Phyto-X, while working in the academic research lab of Professor Vincent M. Rotello.



Share with friends

Date and Time

Location

Altruist Brewing Company

559 Main Street

Sturbridge, MA 01518

View Map

Save This Event

Event Saved